跳至主要内容
临床试验/TCTR20190418003
TCTR20190418003已完成4 期

Comparative Efficacy of Omeprazole plus Mosapride Combination Therapy versus Omeprazole Monotherapy in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease: a randomized controlled trial

Rajavithi Hospital0 个研究点目标入组 44 人开始时间: 2019年4月18日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • the patients who experienced a symptom of heartburn and/or regurgitation more than twice weekly unresponsive to at least 8 weeks of a standard dose of proton pump inhibitor, defined by having the frequency scale for symptoms of gastroesophageal reflux disease total score of eight points or more

排除标准

  • (i) who had a previous history of esophageal or gastrointestinal surgery except appendectomy and cholecystectomy (ii) who had severe cardiac or pulmonary disease, renal failure, liver cirrhosis and severe systemic illness (iii) who had an active Helicobacter pylori infection, determined by both the rapid urease test and histological identification, or upper gastrointestinal diseases such as malignancy or peptic ulcers (iv) who was in a state of pregnancy or lactating woman (v) who were hypersensitivity or allergy to mosapride or omeprazole

研究者

相似试验